The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2a study evaluating the efficacy and safety of sutetinib in patients with advanced non–small-cell lung cancer (NSCLC) harboring uncommon EGFR mutations.
 
Fengying Wu
No Relationships to Disclose
 
Fei Zhou
No Relationships to Disclose
 
Fuyou Zhao
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Jia Yu
No Relationships to Disclose
 
Anweng Xiong
No Relationships to Disclose
 
Jing Zhao
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Guanghui Gao
No Relationships to Disclose
 
Yayi He
No Relationships to Disclose
 
Bing Bo
No Relationships to Disclose
 
Shuyan Meng
No Relationships to Disclose
 
Baohui Han
No Relationships to Disclose
 
Caicun Zhou
No Relationships to Disclose